Skip to main content
. 2014 Dec 15;9(Suppl 2):109–126. doi: 10.2147/IJN.S57928

Figure 1.

Figure 1

Growth curves for (A) male and (B) female rats administered ZnOAE100(−) by gavage for 90 days.a

Notes: aZnOAE100(−) was orally administered to Sprague Dawley rats at doses of 31.25 mg/kg, 125 mg/kg, and 500 mg/kg for 90 days. The results are presented as mean ± standard deviation.

Abbreviations: G1, negative control; G2, vehicle control, G3, 31.25 mg/kg treatment group; G4, 125 mg/kg treatment group; G5, 500 mg/kg treatment group; ZnO, zinc oxide; ZnOAE100(−), 100 nm negatively charged ZnO.